Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada

详细信息    查看全文

• 作者：Louise J Maple-Brown (1) (2) (3)
  Joan Cunningham (1)
  Bernard Zinman (3) (4)
  Mary Mamakeesick (5)
  Stewart B Harris (6)
  Philip W Connelly (7) (8)
  Jonathan Shaw (9)
  Kerin O’Dea (10)
  Anthony J Hanley (11) (3) (4)
  
• 关键词：Aboriginal ; Retinopathy ; Albuminuria ; Peripheral neuropathy ; Perhipheral vascular disease
• 刊名：Cardiovascular Diabetology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：11
• 期：1
• 全文大小：190KB
• 参考文献：1. / Australian Institute of Health and Welfare. The health and welfare of Australia's Aboriginal and Torres Strait Islander people, an overview 2011. Cat no: IHW 42 Canberra: AIHW; 2011.
  2. Vos T, Barker B, Begg S, Stanley L, Lopez AD: Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. / Int J Epidemiol 2009,38(2):470-77. CrossRef
  3. Young TK, Reading J, Elias B, O'Neil JD: Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. / CMAJ 2000,163(5):561-66.
  4. Potential years of life lost at ages 25 to 74 among Status Indians, 1991 to 2001. Statistics Canada, Catalogue no. 82-03-XPE [http://www.statcan.gc.ca/pub/82-03-x/2011001/article/11409-eng.pdf]
  5. Potential years of life lost at ages 25 to 74 among Metis and non-Status Indians, 1991 to 2001. Statistics Canada, Catalogue no 82-03-XPE [http://www.statcan.gc.ca/pub/82-03-x/2011001/article/11408-eng.pdf]
  6. Yu CHY, Zinman B: Type 2 diabetes and impaired glucose tolerance in aboriginal populations: A global perspective. / Diabetes Res Clin Pract 2007,78(2):159-70. CrossRef
  7. Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F: Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. / Diabetes Res Clin Pract 2008,82(1):1-7. CrossRef
  8. Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, Kile E, Walker KA, Wang Z: The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. / Kidney Int 1998,54(4):1296-304. CrossRef
  9. Yeates K, Tonelli M: Chronic kidney disease among Aboriginal people living in Canada. / Clin Nephrol 2010,74(Suppl 1):S57-S60.
  10. Yeates K, Tonelli M: Indigenous health: update on the impact of diabetes and chronic kidney disease. / Curr Opin Nephrol Hypertens 2006,15(6):588-92. CrossRef
  11. Katzenellenbogen JM, Sanfilippo FM, Hobbs MS, Briffa TG, Ridout SC, Knuiman MW, Dimer L, Taylor KP, Thompson PL, Thompson SC: Incidence of and case fatality following acute myocardial infarction in Aboriginal and non-Aboriginal Western Australians (2000-004): a linked data study. / Heart Lung Circ 2010,19(12):717-25. CrossRef
  12. Shah BR, Hux JE, Zinman B: Increasing rates of ischemic heart disease in the native population of Ontario, Canada. / Arch Intern Med 2000,160(12):1862-866. CrossRef
  13. Fearnley E, Li SQ, Guthridge S: Trends in chronic disease mortality in the Northern Territory Aboriginal population, 1997-004: using underlying and multiple causes of death. / Aust N Z J Public Health 2009,33(6):551-55. CrossRef
  14. Maple-Brown LJ, Brimblecombe J, Chisholm D, O'Dea K: Diabetes care and complications in a remote primary health care setting. / Diabetes Res Clin Pract 2004,64(2):77-3. CrossRef
  15. Maple-Brown L, Cunningham J, Dunne K, Whitbread C, Howard D, Weeramanthri T, Tatipata S, Dunbar T, Harper CA, Taylor HR, / et al.: Complications of diabetes in urban Indigenous Australians: the DRUID study. / Diabetes Res Clin Pract 2008,80(3):455-62. CrossRef
  16. Hanley AJG, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, Spence JD, House AA, Brown E, Schoales B, / et al.: Complications of Type 2 Diabetes Among Aboriginal Canadians: Prevalence and associated risk factors. / Diabetes Care 2005,28(8):2054-057. CrossRef
  17. Brimblecombe J, Mackerras D, Garnggulkpuy J, Maypilama E, Bundhala L, Dhurrkay R, Fitz J, Maple-Brown L, Shemesh T, Rowley KG, / et al.: Leanness and type 2 diabetes in a population of indigenous Australians. / Diabetes Res Clin Pract 2006,72(1):93-9. CrossRef
  18. Cunningham J, O'Dea K, Dunbar T, Weeramanthri TS, Zimmet P, Shaw J: Study Protocol - Diabetes and related conditions in urban Indigenous people in the Darwin, Australia region: aims, methods and participation in the DRUID Study. / BMC Public Health 2006, 6:8. CrossRef
  19. Hanley A, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, McLaughlin JR, Zinman B: Complications of Type 2 Diabetes Among Aboriginal Canadians: Increasing the Understanding of Prevalence and Risk Factors. / Canadian Journal of Diabetes 2003,27(4):455-63.
  20. Cunningham J: Diversity of primary health care providers for urban indigenous Australians. / Aust N Z J Public Health 2006,30(6):580-81. CrossRef
  21. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A, Zinman B: The Sandy Lake Health and Diabetes Project: Design, Methods and Lessons Learned. / Chronic Dis Can 1995,16(4):149-56.
  22. Waldram J, Herring DA, Young TK: / Aboriginal Health in Canada: historical, cultural, and epidemiological perspectives. Toronto: University of Toronto Press; 1995.
  23. / World Health Organisation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications Geneva: Department of Noncommunicable Disease Surveillance, WHO; 1999.
  24. Parsons MP, Newman DJ, Newall RG, Price CP: Validation of a point-of-care assay for the urinary albumin:creatinine ratio. / Clin Chem 1999,45(3):414-17.
  25. Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC: Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). / Am J Kidney Dis 2004,44(5):792-98.
  26. O'Connell J, Yi R, Wilson C, Manson SM, Acton KJ: Racial Disparities in Health Status. / Diabetes Care 2010,33(7):1463-470. CrossRef
  27. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV: Diabetes guidelines: easier to preach than to practise? / Med J Aust 2006,185(6):305-09.
  28. Flack JR, Colagiuri S: Final report of the Australian National Diabetes Information Audit and Benchmarking (ANDIAB) 2004. [http://www.health.gov.au/internet/wcms/publishing.nsf/Content/pq-diabetes-pubs-andiab04] (Accessed April 2007)
  29. Bailie RS, Si D, Robinson GW, Togni SJ, D'Abbs PH: A multifaceted health-service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care. / Med J Aust 2004,181(4):195-00.
  30. McDermott RA, Tulip F, Schmidt B: Diabetes care in remote northern Australian Indigenous communities. / Med J Aust 2004,180(10):512-16.
  31. Davis TM, Davis WA, Bruce DG: Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. / Med J Aust 2006,184(7):325-28.
  32. Davis TME, McAullay D, Davis WA, Bruce DG: Characteristics and outcome of type 2 diabetes in urban Aboriginal people: the Fremantle Diabetes Study. / Intern Med J 2007,37(1):59-3. CrossRef
  33. Cass A, Cunningham J, Snelling P, Wang Z, Hoy W: End-stage renal disease in indigenous Australians: a disease of disadvantage. / Ethn Dis 2002,12(3):373-78.
  34. Cass A, Cunningham J, Wang Z, Hoy W: Regional variation in the incidence of end-stage renal disease in Indigenous Australians. / Med J Aust 2001,175(1):24-7.
  35. McDonald S, Maguire G, Duarte N, Wang XL, Hoy W: C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. / Clin Sci (Lond) 2004,106(2):121-28. CrossRef
  36. Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q, Best JD, O'Dea K: Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. / Med J Aust 2003,178(10):495-00.
  37. Yudkin J, Yajnik C, Mohamed-Ali V, Bulmer K: High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. / Diabetes Care 1999,22(2):363-64. CrossRef
  38. Ley SH, Hegele RA, Connelly PW, Harris SB, Mamakeesick M, Cao H, Gittelsohn J, Retnakaran R, Zinman B, Hanley AJ: Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study. / Cardiovasc Diabetol 2010, 9:39. CrossRef
  39. Maple-Brown LJ, Cunningham J, Nandi N, Hodge A, O'Dea K: Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study. / Cardiovasc Diabetol 2010, 9:69. CrossRef
  40. Yeates KE, Cass A, Sequist TD, McDonald SP, Jardine MJ, Trpeski L, Ayanian JZ: Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. / Kidney Int 2009,76(6):659-64. CrossRef
  41. Daniel M, O'Dea K, Rowley KG, McDermott R, Kelly S: Glycated hemoglobin as an indicator of social environmental stress among indigenous versus westernized populations. / Prev Med 1999,29(5):405-13. CrossRef
  42. Shemesh T, Rowley KG, Shephard M, Piers LS, O'Dea K: Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. / Clin Chim Acta 2006,367(1-):69-6. CrossRef
  43. ABS & AIHW (Australian Bureau of Statistics & Australian Institute of Health and Welfare). The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples / Canberra 2005.
  44. Ricci-Cabello I, Ruiz-Pérez I, De Labry-Lima AO, Márquez-Calderón S: Do social inequalities exist in terms of the prevention, diagnosis, treatment, control and monitoring of diabetes? A systematic review. / Health Soc Care Community 2010,18(6):572-87. CrossRef
  45. Ong MA, Weeramanthri TS: Delay times and management of acute myocardial infarction in indigenous and non-indigenous people in the Northern Territory. / Med J Aust 2000,173(4):201-04.
  
• 作者单位：Louise J Maple-Brown (1) (2) (3)
  Joan Cunningham (1)
  Bernard Zinman (3) (4)
  Mary Mamakeesick (5)
  Stewart B Harris (6)
  Philip W Connelly (7) (8)
  Jonathan Shaw (9)
  Kerin O’Dea (10)
  Anthony J Hanley (11) (3) (4)
  
  1. Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia
  2. Division of Medicine, Royal Darwin Hospital, Darwin, NT, Australia
  3. Leadership Sinai Centre for Diabetes, Mt Sinai Hospital, Toronto, Canada
  4. Division of Endocrinology, University of Toronto, Toronto, Canada
  5. Sandy Lake Health and Diabetes Project, Sandy Lake First Nation, London, ON, Canada
  6. Centre for Studies in Family Medicine at The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada
  7. Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael’s Hospital, Toronto, Canada
  8. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
  9. Baker IDI Heart and Diabetes Institute, Melbourne, Australia
  10. Sansom Institute for Health Research, University of South Australia, Adelaide, South, Australia
  11. Department of Nutritional Sciences and Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
  

文摘

Background Indigenous populations of Australia and Canada experience disproportionately high rates of chronic disease. Our goal was to compare cardiovascular (CVD) risk profile and diabetes complications from three recent comprehensive studies of diabetes complications in different Indigenous populations in Australia and Canada. Methods We compared participants from three recent studies: remote Indigenous Australians (2002-2003, n = 37 known diabetes), urban Indigenous Australians (2003-2005, n = 99 known diabetes), and remote Aboriginal Canadians (2001-2002, n = 188 known diabetes). Results The three groups were similar for HbA1c, systolic BP, diabetes duration. Although leaner by body-mass-index criteria, remote Indigenous Australians displayed a more adverse CVD risk profile with respect to: waist-hip-ratio (1.03, 0.99, 0.94, remote Indigenous Australians, urban Indigenous Australians, remote Canadians, p < 0.001); HDL-cholesterol (0.82, 0.96, 1.17 mmol/L, p < 0.001); urine albumin-creatinine-ratio (10.3, 2.4, 4.5 mg/mmol); and C-reactive protein. With respect to diabetes complications, microalbuminuria (50%, 25%, 41%, p = 0.001) was more common among both remote groups than urban Indigenous Australians, but there were no differences for peripheral neuropathy, retinopathy or peripheral vascular disease. Conclusions Although there are many similarities in diabetes phenotype in Indigenous populations, this comparison demonstrates that CVD risk profiles and diabetes complications may differ among groups. Irrespective, management and intervention strategies are required from a young age in Indigenous populations and need to be designed in consultation with communities and tailored to community and individual needs.